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Malaria remains uncontrolled to-date due to lack of effective parasite and vector control strategies.
With the completion of the host, parasite and vector genome projects more suitable and effective
disease control measures can be achieved. Here we have reviewed the Plasmodium falciparum ge-
nome project and its impact on malaria research in future. The parasite genome project has revealed
certain metabolic pathways which can be targeted to develop antimalarial drugs. It has also identi-
fied large number of potential antigens for the future potential vaccines. Now the researchers in the
malaria field can plan to take up the studies, which can yield more fruitful results within the limited
financial resources using bioinformatics, proteomics, structural, functional and comparative genom-
ics, etc.
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Malaria  is the most serious and wide spread para-
sitic disease of humans. Around 40% of the world’s
population reside in malaria affected areas. Each
year, there are approximately 400 million cases with
2.5 to 3 million deaths due to  malaria1.  The great-
est malaria mortality rates have been estimated in
Sub-Saharan Africa where children account for
90% of all deaths2. Of the four   Plasmodium spe-
cies, which use human as their vertebrate host,
Plasmodium falciparum is the most lethal and pro-
bably the third most studied pathogen after HIV
and TB1,3.
P. falciparum has a complex life cycle involving
two different hosts—human and the female
Anopheles mosquito.  In each host, the parasite
passes through several stages to grow and multi-
ply further.  Large number of stage specific genes
are expressed by the parasite for its survival in its
hostile host. With the development of in vitro cul-
ture (for the clinically relevant intra-erythrocytic
stages of the parasite) and the molecular tools (such
as transfection, microarray, etc.) the  P. falciparum
biology has evolved very rapidly over the last 25
years.
It was the year 1996, when an International Consor-
tium of Scientists from various institutions set a goal
to determine the sequence of P. falciparum genome
because the human genome project was already pro-
gressing at a satisfying speed4.  After seven years, in
October 2002, the project was completed which
provided a vast genetic information.  Also to delight
of malariologists, the genome of the anopheline vec-
tor was simultaneously completed. Now, we have all
the genetic information of all the three partners in-
volved in the game — the human host, the mosquito
vector, and Plasmodium (the parasite). This should
expedite research efforts in the field of malaria.
Here, we have attempted to review the information *Corresponding authorJ  VECT  BORNE  DIS  40,  MARCH–JUNE  2003 10
emerged from the parasite genome project and its
utility in future malaria research.
Genome in nutshell
Nuclear genome: The 22, 853, 764 bases of the ge-
nome are organised in the form of 14 chromosomes
ranging in size from 0.643 to 3.24 Mb where chromo-
some 1 is the smallest and 14 the largest. Sequencing
of the P. falciparum chromosomes 1, 3, 4, 5, 6, 7, 8,
9 and 13 has been performed by the Sanger Institute,
UK,  whereas chromosomes 2,10,11 and 14 by
TIGR, USA, and the chromosome 12 by the Stanford
Genome Technology Centre.  The highly A+T rich
(80.6%) genome has around 5,268 genes.   Seventy
per cent of these gene products have been detected
by proteomic analysis and have also matched the ex-
pressed sequence tags (ESTs).  Analysis has shown
that 52.6% of the genome constitutes coding region.
On an average there are 2.39 exons per gene with
23.7% G+C content. Roughly 54% of the genes have
been predicted to contain introns. A total of 7,406 in-
trons have been identified with an average length of
178.7 bp with G+C content of 13.5%.  As expected
introns and other non-coding regions are more A+T-
rich than the exons. Sequencing has revealed 43
tRNA genes binding to all codons except the two
coding for cysteine (TGT and TGC). There are three
5S rRNA genes and seven genes for other rRNAs.
35 kb circular DNA:  The 35 kb circular apicoplast
encodes for only 30 proteins5.    Rest of the proteins
are imported from the cytoplasm and thus are nuclear
encoded.  Laboratory and computational based meth-
ods have estimated approximately 550 proteins
which are targeted to the apicoplast6.  These include
important enzymes catalysing DNA replication, repair,
transcription, translation and post-translational modifi-
cations, cargo proteins and proteins for other activi-
ties.  No photosynthetic genes have been found.
Mitochondrial genome: The mitochondrial genome,
present in all malarial species, consists of a multicopy
6 kb tandemly repeated element. It is conserved
across the phylum  apicomplexan7–9. Electron micros-
copy detected primarily linear forms of varying length,
perhaps reflecting the variance in number of tandemly
repeated 6 kb element. Nucleotide sequence has been
determined from various Plasmodium species which
is highly conserved10–13.
The 6 kb elements of all the Plasmodium species are
known to have genes for cytochrome oxidase subunit
I & III and cytochrome b.  Majority of the mitochon-
drial proteins are, therefore, nuclear coded. This ele-
ment is also found to contain large number of  frag-
mented ribosomal RNA genes but no tRNA gene14.
Malarial mitochondrial genome has a slightly different
base composition (68% A+T) from that of the nuclear
genome.   It has been shown that the majority of the
mitochondrial DNA consisted of polydispersed head
to tail tandem arrays of the 6 kb element in the size
range of 6–23 kb and circular forms account only for
approximately 1–2%15.
Proteome: The genomic data of P. falciparum pro-
vided a foundation to perform proteomic studies.
Since, the life cycle of this organism consists of several
distinct stages, each requiring specific expression of
genes, the proteomic studies were carried out for dif-
ferent stages.  Multi dimensional protein identification
technology was applied to characterise the pro-
teomes.  The technology combines in-line, high  reso-
lution liquid chromatography and tandem mass spec-
trometry16.  Total 5,268 proteins have been predicted
out of which 3,208 are categorised into hypothetical
proteins. A total of 551 proteins are targeted to the
apicoplast and 246 to the mitochondria.  About 1,631
proteins were found to contain transmembrane do-
mains and 544  contained signal peptides17.
Results of comparative proteomics from sporozoite,
merozoite, trophozoite and gametocyte stages showed
that they contained 1,049, 839, 1,036 and 1,147 pro-
teins respectively18.  Only 152 proteins, which consti-
tute 6% of the total proteome, were found to be com-
mon to all stages.  These common proteins include
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cytoskeletal proteins. Protein analysis has also shown
that the proteins expressed in the sporozoite stage are
different from the other stages. On the contrary, mero-
zoites, trophozoites and gametocytes have only 20%
stage specific proteins18.
Functional features of the genome
Enzymes: Out of 5,268 genes, the products of 733
genes have been identified as enzymes, playing an im-
portant role in the metabolism of the organism. Of
them 435 proteins have been assigned the Enzyme
Commission (EC) numbers.  Enzymes required in gly-
colysis,  TCA cycle, pentose phosphate pathways are
present but a gene encoding fructose bis-phosphate
could not be detected. Identified genes encoding im-
portant enzymes include ATP synthase, purine trans-
porters and nucleoside interconversion enzymes,
heme biosynthesis enzymes, enzymes involved in type
II fatty acid biosynthesis (except thioesterase), three
enzymes of the mevalonate-independent isoprenoid
synthesis—1-deoxy-D-xylulose-5-phosphate synthase,
1-deoxy-D-xylulose-5-phosphate reductoisomerase
and 2C-methyl-D-erythritol 2,4-cyclo diphosphate
synthase19, 20.  P. falciparum also have genes encod-
ing enzymes for chorismate synthesis from erythrose
4-phosphate and phosphophenol pyruvate through
shikimate pathway21–24.
Transporter and secretary proteins: Genomic analy-
sis shows a very limited number of transporter proteins
as compared to other eukaryotes correlating with the
lower percentage of multi spanning membrane proteins.
Identified transporters include water/glycerol channel
proteins, glucose/proton symporters, one expected
sugar transporter, three carboxylate transporters, two
nucleoside/nucleobase transporters, nine members of
the mitochondria carrier family including an ATP/ADP
exchanger25 and a di/tri carboxylate exchanger which is
perhaps involved in the transport of TCA cycle interme-
diates across mitochondrial membrane, phosphoenol
pyruvate/phosphate and sugar phosphate/phosphate
antiporters, transporters of inorganic ions, drugs and
hydrophobic compounds, Na+/proton, Ca++/proton
exchangers, metal cation transporters, all units of
V-type ATPases, proton pumping pyrophosphatases
and a number of other transporters. During the analy-
sis no amino acid transporter was identified1.
Homologues of important components of SRPs, trans-
locons, signal peptidase complex, vesicle assembly
components and proteins for docking and fusion like
Cop I, Cop II, clathrin, adaptin, GTP binding proteins,
etc. have been found.
Nucleic acid related proteins: The core proteins in-
volved in nucleotide excision repair (XPB/Rad 25,
XPG/Rad 2, XPF/Rad 1, XPD/Rad 3, ERCCI) and
for homologous recombinational repair (Rad 50, Rad
51, MRE II and DMC I) are present in P. falciparum
genome but their accessory proteins could not be
found.  The ability of P. falciparum to perform post-
replication mismatch repair proves with the presence
of Mut L and Mut S homologues.  Genes or their ho-
mologous encoding enzymes for non homologous end
joining were absent explaining some of the unusual
properties of the telomeres in this species1.
Proteins for immunological avoidance: 59 var,
149 rif and 28 stevor  genes coding for P. falci-
parum erythrocyte membrane proteins (pfEMP1), re-
petitive interspersed family (rifin) and subtelomeric
variable ORF (stevor) are present.  The products of
the var genes are transported to the membrane and
infected RBCs.  The proteins mediate adherence to
host endothelial receptors26.  Var gene products and
rifins are responsible for antigenic variation leading to
the immune evasion allowing chronic infection and
transmission thus var proteins are principally involved
in the induction of protective immunity.  Rifins are also
expressed on the surface of infected red cells.  The
exact function of rifins and stevors is unknown and
needs to be investigated.
Possible harvestings from the genome
Facilitating basic malaria research: This is certain
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research of this parasite, manifolds.  The genome will
help to understand the P. falciparum biology more
clearly as well as it will provide a firm foundation for
starting new research.  For example with the help of the
genes involved in protein transport, probes can be
made which will help in establishing the mechanisms as
well as defining the components of protein transport
systems.  In the genome a number of genes with un-
known function, have been predicted.  With the help
of their sequence, their protein functions will be deter-
mined.
The availability of P. falciparum genome will clear the
way for more in silico analysis of stage specific tran-
scription patterns.  The comprehensive study of its bi-
ology is needed in order to search for novel drug tar-
gets and vaccine developments.
Drug targeting: With the help of the malaria genome
data, various biochemical pathways important for the
survival of the malaria parasite can be targeted for
drug development.  The study of a number of genes
encoding different transcription factors, proteins in-
volved in signal transduction, enzymes, etc. will help in
the screening for new antimalarial drugs.  For exam-
ple, even after the years of study the exact mode of
action of quinoline antimalarial and the mechanisms of
parasite resistance to these drugs are still not com-
pletely understood.  If the molecular targets of the
quinolines could be identified and the molecular basis
of resistance defined, it might be possible to develop
new drugs that target the same metabolic processes
but somehow evade the resistance mechanisms.  Ma-
laria parasite induces new permeation pathways, in
part, by increased activity of endogenous transporters
thereby increasing the permeability of malaria infected
erythrocytes to a wide range of solutes.  With the help
of genome data, genes encoding transporter proteins
as well as proteins themselves can be exploited as
drug targets.
Serial analysis of gene expression (SAGE), combined
with the information available through the malaria ge-
nome project, could increase our knowledge and
point the way to new drug targets.  The technology
can be used to identify genes (or gene clusters) whose
expression levels are affected when the parasite is
treated with cytotoxic drug.  Different responses in
parasites that are resistant to a particular drug can also
be monitored.
Vaccine development: The most important use of ge-
nome data would be to develop an effective vaccine
against this disease. Effective vaccine aims to stimulate
the humoral and/or cellular immune response.  Anti-
bodies, produced by B-lymphocytes are effective in
the protection against extracellular stages of viruses
and parasites,  whereas cell mediated immunity re-
flected by cytolytic lymphocytes and production of
cytokines by T-helper cells of Th1 subset (particularly
the macrophage-activating lymphokine interferon
gamma IFN-γ), is essential to defend the host against
intracellular stages of the parasites.
The P. falciparum genome will enhance the vaccine
development by the detection of the potential antigens,
that could be screened for derived characteristics like
surface expression or limited antigenic diversity by
stage-specific gene expression and proteomic analysis.
On one hand the proteome of the P. falciparum will
facilitate the discovery of novel subunit vaccines com-
posed of purified proteins and polysaccharide antigens,
on the other hand the genomic sequence will facilitate
the discovery of new DNA vaccines in which an antigen
coding gene is inserted into suitable expression vector
(plasmid) and the purified recombinant vector encoding
the immunogen is injected into the host.
Comparative genomics: Comparative studies are
very useful for the annotation of any unannotated ge-
nome.  The genome sequence of P. falciparum will
provide a mean to the other ongoing sequencing
projects of the other species of Plasmodium for their
annotation.  The function of a gene can be predicted
by comparing the homology between its nucleotide
sequence with the sequences of other genes of known
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experiments can be performed in the right direction to
confirm them.
Comparative genomics is also useful to unfold the
evolutionary history among genes, proteins or the
whole organisms.  Comparative studies of P. falci-
parum genome with the other available genomes have
shown that it is more similar to Arabidopsis thaliana
in terms of whole genome content1.
Another application of comparative genomics is to
search for any suitable species, different from the
pathogen, that can be modelled to study that disease.
Model species should have a number of features de-
pending on the type of study.  In order to study a dis-
ease, the model organism should have conserved im-
munologic responses as well as the homologous
genes, involved in pathogenicity.  Comparative studies
can prove or disapprove any organism to be a model.
For example, P. yoelii, the rodent malaria parasite,
has long been used as model for malaria research  as
it shows similarity in many biological responses to that
of the human malaria parasite  P. falciparum27.
Comparative analysis has shown that a number of fea-
tures are common between the  two species.  Synteny
is highly conserved between the two species in region
of house keeping genes but low in the genes involved
in antigenic variation27.
The Yir gene family is the largest family of genes in P.
yoelii yoelii genome having 838 Yir genes in totality.
The Yir gene family is homologous to the Yir multi
gene family in P. vivax which encodes proteins show-
ing immunovariation in natural infection27.  The Yir
family in P. yoelii yoelii makes it a good model sys-
tem for studying antigenic variation in P. vivax.
Diagnostics: Accurate diagnosis is the key step to
cure any disease effectively.  Apart from the charac-
teristic symptoms of malaria, the correct identification
of the causing species is required to confirm the dis-
ease and to begin the treatment.  Now a days a num-
ber of diagnostic approaches are applied of which
PCR based approaches have special attentions. The
high accuracy of the technique, giving results in very
short time, has made it a versatile diagnostic approach
particularly the drug resistant cases.  The P. falci-
parum genome is undoubtedly going to provide the
correct and specific target sequences which can be
identified through PCR from the blood samples.
Conclusion
The availability of the genome of P. falciparum will
provide numerous opportunities for research on this
organism.  The information which is generated from
the sequencing of the genome is extremely useful in
developing effective drugs and vaccines to combat this
disease.  No doubt that the malaria genome in con-
junction with the genome information on its host and
vector will energise the investigators  to develop better
and newer control strategies.
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